NAMALWA In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF4197
Target Cell Organism: Human
Target Cell Name: NAMALWA
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NAMALWA-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NAMALWA
Target Cell Organism
Human
Target Cell Background
NAMALWA is a B lymphocyte isolated from a three-year-old patient with Burkitt's lymphoma. This cell line was deposited by NB Finter and can be in immunology research.
Related Diseases
Burkitts Lymphoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry